Pathologic and clinical features influencing outcome of thin cutaneous melanoma: Correlation with newly proposed staging system

American Surgeon

Volumn 66, Issue 6, 2000, Pages 527-532

  Finley, J William ^a   Gibbs, John F ^b,c   Rodriguez, Luz M ^b   Letourneau, Richard ^b   Driscoll, Deborah ^b   Kraybill, William ^b  

^a GEISINGER MEDICAL CENTER   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CORRELATION FUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MELANOMA; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0034041620     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Mansson-Brahme E, Cartensen J, Erhardt K, et al. Prognostic factors in thin cutaneous malignant melanoma. Cancer 1994;73: 2324-32.
2. National Institutes of Health Consensus Development Conference Statement on Diagnosis and Treatment of Early Melanoma, January 27-29, 1992. Am J Dermatopathol 1993;15:34-43.
3. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;46:5-28.
4. Friedman RJ, Rigel DS, Silverman MD, et al. Malignant melanoma in the 1990s. CA Cancer J Clin 1991;41:201-26.
5. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
6. Park KGM, Blessing K, McLaren KM, Watson ACH. A study of thin malignant melanomas with poor prognosis. Br J Plast Surg 1993;46:607-10.
7. Burton RC, Armstrong BK, Phil D. Current melanoma epidemic: A non-metastasizing form of melanoma? World J Surg 1995;19:330-3.
8. NIH Consensus Conference. Diagnosis and treatment of early melanoma. JAMA 1992;268:1314-9.
9. Buzaid AC, Ross MI, Balch CM, et al. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol 1997;15:1039-51.
10. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, eds. American Joint Committee on Cancer: Manual for Staging of Cancer, 4th Ed. Philadelphia: Lippincott, 1992, pp 143-8.
11. Morton DL, Davtyan DG, Wanek LA, et al. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness. Cancer 1993;71:3737-43.
12. Shaw HM, McCarthy WH, McCarthy SW, Milton GW. Thin malignant melanomas and recurrence potential. Arch Surg 1987;122:1147-50.
13. Slingluff CL, Vollmer RT, Reintgen DS, Seigler HF. Lethal "thin" malignant melanoma: Identifying patients at risk. Ann Surg 1988;208:150-61.
14. Veronesi U, Cascinelli N. Narrow excision (1 cm margin): A safe procedure for thin cutaneous melanoma. Arch Surg 1991; 126:438-41.
15. Buttner P, Garbe C, Bertz J, et al. Primary cutaneous melanoma: Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. Cancer 1995;75: 2499-506.
16. Kelly JW, Sagebiel RW, Clyman S, Blois MS. Thin level IV malignant melanoma. Ann Surg 1985;202:98-103.
17. Blessing K, McLaren KM, McLean A, Davidson P. Thin melanomas with metastasis: A histological study and survival analysis. Histopathology 1990;17:389-95.
18. Balch CM, Soong SJ, Milton GW, et al. A comparison of prognostic factors and surgical results in 1786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg 1982;196:677-84.
19. Vollmer RT. Malignant melanoma: A multivariate analysis of prognostic factors. Pathol Ann 1989;24:383-407.
20. Day CL, Lew RA, Mihm MC, et al. The natural breakpoints for primary tumor thickness in clinical stage I melanoma. N Engl J Med 1981;305:1155.
21. Pontikes LA, Temple WJ, Cassar SL, et al. Influence of level and depth on recurrence rate of thin melanomas. Am J Surg 1993;165:225-8.
22. Brandt SE, Welvaart K, Hermans J. Is long term follow-up justified after excision of a thin melanoma? J Surg Oncol 1990; 43:157-60.
23. Balch C. Cutaneous melanoma: Prognosis and treatment results worldwide. Semin Surg Oncol 1992;8:400-14.
24. Slingluff C, Seigler HF. "Thin" malignant melanoma: Risk factors and clinical management. Ann Plast Surg 1992;28:89-94.
25. Emilia JCD, Lawrence W. Sentinel lymph node biopsy in malignant melanoma: The standard of care? J Surg Oncol 1997; 65:153-4.